Macrogenics Stock (NASDAQ:MGNX), Quotes and News Summary

Q: What sector and industry does Macrogenics (MGNX) operate in?

Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Macrogenics Stock (NASDAQ: MGNX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.573M
Day Range	- - -
52 Wk Range	4.290 - 21.880
Market Cap	$1.005B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	12.65%
Days to Cover	6.32

Recent News

Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82%

Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see an 82% surge. The revised targets include four U.S.-listed companies, with the most significant upgrade forecasted for a biopharmaceutical firm.

Benzinga Neuro

MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidate

Update on MacroGenics Inc's Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo) for metastatic castration-resistant prostate cancer (mCRPC). Safety and preliminary efficacy data anticipated by May 31. JMP Securities notes enhanced safety profile with new dosing regimen.

Vandana Singh

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3% to $44.30 on Thursday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Macrogenics Inc

Sector

Health Care

Industry

Biotechnology

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based ther...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Macrogenics (MGNX) stock?

You can purchase shares of Macrogenics (NASDAQ: MGNX) through any online brokerage.

View our list of the best stock brokerages.

Who are Macrogenics's (MGNX) competitors?

Other companies in Macrogenics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Centessa Pharmaceuticals (NASDAQ:CNTA).

What is the target price for Macrogenics (MGNX) stock?

The latest price target for Macrogenics (NASDAQ: MGNX) was reported by TD Cowen on Tuesday, April 9, 2024. The analyst firm set a price target for 0.00 expecting MGNX to fall to within 12 months (a possible -100.00% downside). 18 analyst firms have reported ratings in the last year.

Current Stock Price for Macrogenics (MGNX)?

The stock price for Macrogenics (NASDAQ: MGNX) is $16.07 last updated April 18, 2024 at 4:00 PM EDT.

Does Macrogenics (MGNX) pay a dividend?

There are no upcoming dividends for Macrogenics.

When is Macrogenics (NASDAQ:MGNX) reporting earnings?

Macrogenics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Macrogenics (MGNX) going to split?

There is no upcoming split for Macrogenics.

What sector and industry does Macrogenics (MGNX) operate in?

Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-